Healthcare organizations are prime targets for class action lawsuits. The healthcare industry tops the list for class action data breach lawsuits. Healthcare is among the top-three industries facing class action lawsuits around the Telephone Consumer Protection Act (TCPA)—despite a TCPA exemption for health-related calls. And that’s just the tip of the iceberg. From mounting litigation around opioids to the growing number of suits claiming excessive hospital charges, healthcare organizations are increasingly the victims of class actions.
Now, for the first time in 15 years, Federal Rule of Civil Procedure 23, which governs class actions, has been amended. The changes took effect December 1, 2018. What do the changes mean for healthcare organizations? How are the new amendments likely to impact federal class action litigation? And what do you need to know about the new requirements? Find out in a new Manatt webinar. Key topics include:
- Updates to Rule 23’s requirements for notifying class members to include technological advances
- New requirements around notice of proposed class settlements
- New core factors that the court should evaluate in deciding whether to approve a settlement
- New amendments to discourage bad faith, “professional” objectors while facilitating good faith objectors who are not represented by counsel
- Important clarifications on whether orders directing notice of a proposed settlement can be appealed
- A look at the newest trends, including the latest updates to the Northern District of California’s Comprehensive Procedural Guidance for Class Action Settlements—and what may be coming in other states
Presenters
Sarah Gettings, Partner, Litigation
Joseph Laska, Partner, Litigation
Date and Time
Tuesday, April 9, 2019
If you would like to receive an audio transcript of this webinar due to accessibility issues, please email us at webinars@manatt.com.
This program does not constitute legal advice, nor does it establish an attorney-client relationship. Views expressed by presenters are strictly their own and should not be construed to be the views of Manatt or attributed to Manatt.